We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J Urged to Cut Price of Its Anti-Tuberculosis Drug
J&J Urged to Cut Price of Its Anti-Tuberculosis Drug
Doctors Without Borders called on Johnson & Johnson to lower the cost of its anti-tuberculosis drug bedaquiline to $1 or less per day and allow other drugmakers to make generic versions.